Login / Signup

Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.

Nikolaus A HandkeAlexander B A RuppNicolai TrimpopJoachim von PawelStefan Holdenrieder
Published in: Diagnostics (Basel, Switzerland) (2021)
Soluble HMGB1 is a promising biomarker for prediction of therapy response and prognosis in advanced NSCLC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • small cell lung cancer
  • peritoneal dialysis
  • transcription factor
  • patient reported outcomes
  • mesenchymal stem cells